Authors:
Kuehm-Caubere, C
Caubere, P
Jamart-Gregoire, B
Pfeiffer, B
Guardiola-Lemaitre, P
Manechez, D
Renard, P
Citation: C. Kuehm-caubere et al., Novel thiopyrano[3,2-b] and cycloalkeno[1,2-b]indole derivatives with highinhibitory properties in LTB4 production, EUR J MED C, 34(1), 1999, pp. 51-61
Authors:
Kopp, C
Vogel, E
Rettori, MC
Delagrange, P
Renard, P
Lesieur, D
Misslin, R
Citation: C. Kopp et al., Antagonistic effects of S 22153, a new mt1 and MT2 receptor ligand, on theneophobia-reducing properties of melatonin in BALB/c mice, PHARM BIO B, 64(1), 1999, pp. 131-136
Authors:
Ansar, M
Ebrik, S
Mouhoub, R
Vaccher, C
Vaccher, MP
Flouquet, N
Bakkas, S
Taoufik, J
Debaert, M
Caignard, DH
Renard, P
Berthelot, P
Citation: M. Ansar et al., Isomers of substituted 3-benzo[b]furyl and 3-thienylaminobutyric acids as potent ligands of the GABA-B receptor: synthesis and preparative liquid chromatographic separation, THERAPIE, 54(5), 1999, pp. 651-658
Authors:
Le Bihan, G
Rondu, F
Pele-Tounian, A
Wang, X
Lidy, S
Touboul, E
Lamouri, A
Dive, G
Huet, J
Pfeiffer, B
Renard, P
Guardiola-Lemaitre, B
Manechez, D
Penicaud, L
Ktorza, A
Godfroid, JJ
Citation: G. Le Bihan et al., Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-,1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4 ',5 '-dihydro-1' H-imidazol-2 '-yl)piperazines and isosteric analogues of imidazoline, J MED CHEM, 42(9), 1999, pp. 1587-1603
Authors:
Jellimann, C
Mathe-Allainmat, M
Andrieux, J
Renard, P
Delagrange, P
Langlois, M
Citation: C. Jellimann et al., Melatonergic properties of the (+)- and (-)-enantiomers of N-(4-methoxy-2,3-dihydro-1H-phenalen-2-yl) amide derivatives, J MED CHEM, 42(6), 1999, pp. 1100-1105
Authors:
Poudrel, JM
Hullot, P
Vidal, JP
Girard, JP
Rossi, JC
Muller, A
Bonne, C
Bezuglov, V
Serkov, I
Renard, P
Pfeiffer, B
Citation: Jm. Poudrel et al., Synthesis and structure-activity relationships of new 1,3-disubstituted cyclohexanes as structurally rigid leukotriene B-4 receptor antagonists, J MED CHEM, 42(26), 1999, pp. 5289-5310
Authors:
Kroll, M
Margottin, F
Kohl, A
Renard, P
Durand, H
Concordet, JP
Bachelerie, F
Arenzana-Seisdedos, F
Benarous, R
Citation: M. Kroll et al., Inducible degradation of I kappa B alpha by the proteasome requires interaction with the F-box protein h-beta TrCP, J BIOL CHEM, 274(12), 1999, pp. 7941-7945
Authors:
Pele-Tounian, A
Chan, SLF
Rondu, F
Le Bihan, G
Giroix, MH
Lamouri, A
Touboul, E
Pfeiffer, B
Manechez, D
Renard, P
Guardiola-Lemaitre, B
Godfroid, JJ
Penicaud, L
Morgan, NG
Ktorza, A
Citation: A. Pele-tounian et al., Effect of the new imidazoline derivative S-22068 (PMS 847) on insulin secretion in vitro and glucose turnover in vivo in rats, EUR J PHARM, 377(1), 1999, pp. 81-87
Authors:
Weibel, L
Rettori, MC
Lesieur, D
Delagrange, P
Renard, P
Van Reeth, O
Citation: L. Weibel et al., A single oral dose of S 22153, a melatonin antagonist, blocks the phase advancing effects of melatonin in C3H mice, BRAIN RES, 829(1-2), 1999, pp. 160-166
Authors:
Savelon, L
Bizot-Espiard, JG
Caignard, DH
Pfeiffer, B
Renard, P
Viaud, MC
Guillaumet, G
Citation: L. Savelon et al., 6-aminoalkyloxazolo[4,5-b]pyridin-2(3H)-ones: Synthesis and evaluation of antinoceptive activity, BIO MED CH, 6(11), 1998, pp. 1963-1973
Authors:
Pirotte, B
de Tullio, P
Podona, T
Diouf, O
Dewalque, D
Neven, P
Masereel, B
Caignard, DH
Renard, P
Delarge, J
Citation: B. Pirotte et al., Pyridothiadiazinedioxides structurally related to quinazolinones cholecystokinin gastrin receptor ligands: synthesis and biological evaluation, EUR J PH SC, 7(1), 1998, pp. 29-40
Authors:
Christophe, S
Kuehm-Caubere, C
Renard, P
Pfeiffer, B
Caubere, P
Citation: S. Christophe et al., Design of new anticancer drugs. II. Easy arynic access to benzocyclobutacarbazoles, a new family of antitumor agents, TETRAHEDR L, 39(51), 1998, pp. 9431-9434